Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Company Overview - Agyant Technologies is a leader in analytical instruments, software services, and consumables for life sciences, diagnostics, and applied chemical markets, helping scientists unlock insights with precision and confidence [2][3] - The company is known for its innovation and reliability, enabling breakthroughs in cancer research, drug development, and other key areas [3] Financial Performance - Agyant reported a strong third quarter with a core growth of 6.1%, translating to approximately $1.74 billion in revenue and an EPS of $1.37, exceeding expectations [4] - This marks the fifth consecutive quarter of growth acceleration, driven by excellent execution, innovative new products, and high customer satisfaction scores exceeding 90% [4] Market Segments - The pharmaceutical market, Agyant's largest segment, grew by 9%, while the chemical and advanced materials sub-markets grew by 10%, and the food markets grew by 7% [4] - The PAS (forever chemicals) division is one of the fastest-growing areas, with broad-based double-digit growth driven by increasing regulation and consumer awareness [5] Global Presence and Tariff Impact - Agyant has a long-standing presence in China and reported a solid quarter there, effectively mitigating tariff impacts through investments in local manufacturing and supply chain adjustments [6][7] - The Ignite transformation initiative is a company-wide effort aimed at improving operational efficiency and long-term value creation, which has helped mitigate tariff impacts and is expected to continue providing benefits [8][9][10] Customer Focus - Agyant emphasizes a customer-first strategy, investing in application engineers and technical capabilities to ensure high customer satisfaction and effective use of their instruments [12][13]